Le Lézard
Classified in: Health, Science and technology, Business
Subjects: STOCK/OTHER MARKET NEWS, MISCELLANEOUS

Wildflower Brands Announces Official Uplisting to OTCQB Venture Market Exchange


VANCOUVER, British Columbia, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Wildflower Brands Inc. (CSE: SUN, OTC:WLDFF) (the "Company") is excited to announce that the Company has been approved by the OTC Markets Group (the "OTC") to officially transition to the OTCQB "Venture Market" tier with the OTC ticker symbol WLDFF.

Listing on the OTCQB is a significant milestone for Wildflower Brands. Although Wildflower Brands is listed and predominantly traded on the Canadian Securities Exchange, our OTCQB listing provides better access to institutional investors and a broader shareholder base through the transparency and credibility of the listing.

The OTCQB is recognized as an Established Public Market by the U.S. Securities and Exchange Commission and is a leading market for U.S. and international companies in the entrepreneurial and development stage. To be eligible, companies must be current in their financial reporting, pass a minimum bid price test, and undergo an annual company verification and management certification process. The OTCQB Venture Market quality standards provide a strong baseline for transparency, as well as the technology and regulation to improve the information and trading experience for investors. As a verified market with efficient access to U.S. investors, OTCQB helps companies build shareholder value with a goal of enhancing liquidity and achieving a fair valuation.

This announcement complements recent plans for expansion and growth. Our OTCQB listing creates opportunities for advantageous terms on financing for our work with Retail Worx, the acquisition of the Alchemist Kitchen, and funding our expansion of operations in California.

William MacLean, CEO of Wildflower says, "Uplisting Wildflower Brands in the US strengthens our aggressive growth strategy. There is a loyal following for our brands that are available in the US, and this has translated into significant interest in our company from American investors. Our OTCQB listing provides an easy way of investing in Wildflower Brands."

ABOUT WILDFLOWER BRANDS

Wildflower Brands is a company headquartered in Vancouver building reputable brands and quality products that incorporate the synergistic effects of plants and their extracts.

On Behalf of the Board of Directors

"William MacLean"
____________________________________
William MacLean
Director and CEO

Cautionary and Forward-Looking Statements

This news release contains forward?looking statements and forward?looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward?looking statements or information. Forward?looking statements and information are often, but not always, identified by the use of words such as "appear", "seek", "anticipate", "plan", "continue", "estimate", "approximate", "expect", "may", "will", "project", "predict", "potential", "targeting", "intend", "could", "might", "should", "believe", "would" and similar expressions.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward?looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the risks associated with the marijuana industry in general such as operational risks in growing; competition; incorrect assessment of the value and potential benefits of various transactions; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and government regulations. Accordingly, readers should not place undue reliance on the forward?looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forward?looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward?looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.

The Canadian Securities Exchange Inc. has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved of the contents of this press release.

400-1505 West 2nd Ave,
Vancouver, B.C., V6Y 3Y4
Tel: (604) 559-0420
                                                                                                                       www.wildflowerbrands.co
[email protected]
   

These press releases may also interest you

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...



News published on and distributed by: